ANNEE 2022

Publié le 12/12/2023 à 12h04 (mis à jour le 22/12/2023 à 10h40)

PHARMACOLOGIE FONDAMENTALE ET CLINIQUE, RECHERCHE CLINIQUE

Aguersf A, Sarton B, Bouharaoua S, Gaillard L, Standarovski D, Faucoz O, Martin Blondel G, Khallel H, Thalamas C, Sommet A, Riu B, Morand E, Bataille B, Silva S. Lung Ultrasound to Assist ICU Admission Decision-Making Process of COVID-19 Patients With Acute Respiratory Failure. Crit Care Explor. 2022 Jun 8 ;4(6):e0719.-

Belančić A, Sans-Pola C, Jouanjus E, Alcubilla P, Arellano AL, Žunić M, Nogueiras-Álvarez R, Roncato R, Sáez-Peñataro J ; EACPT Young Clinical Pharmacologists Working Group. European association for clinical pharmacology and therapeutics young clinical pharmacologists working group : a cornerstone for the brighter future of clinical pharmacology. Eur J Clin Pharmacol. 2022 Apr ;78(4):691-694.

Betrouni N, Moreau C, Rolland AS, Carrière N, Viard R, Lopes R, Kuchcinski G, Eusebio A, Thobois S, Hainque E, Hubsch C, Rascol O, Brefel C, Drapier S, Giordana C, Durif F, Maltête D, Guehl D, Hopes L, Rouaud T, Jarraya B, Benatru I, Tranchant C, Tir M, Chupin M, Bardinet E, Defebvre L, Corvol JC, Devos D ; PREDISTIM Study Group. Can Dopamine Responsiveness Be Predicted in Parkinson’s Disease Without an Acute Administration Test ? J Parkinsons Dis. 2022 ;12(7):2179-2190.

Bordet R, Dontonel JC, Vacaresse E, Le Jeune C, Benhabiles N, Beretz A, Boitard C, Debette S, Duluc G, Frogel P, Garbil B, Lyonnet S, Mahfoudi A, Marquet P, Mouthon F, Rascol O, Richard V, Simon E, Varoqueaux N, Watier H, Zins M. How has the future investment program stimulated research and innovation in health ?
Therapie. 2022 Jan-Feb ;77(1):19-24

Boussac M, Arbus C, Colin O, Laurencin C, Eusebio A, Hainque E, Corvol JC, Versace N, Rascol O, Rousseau V, Harroch E, Ory-Magne F, Fabbri M, Moreau C, Rolland AS, Jarraya B, Maltête D, Drapier S, Marques A-R, Auzou N, Wirth T, Meyer M, Giordana B, Tir M, Rouaud T, Devos D, Brefel-Courbon C ; PREDISTIM study group. Personality assessment with Temperament and Character Inventory in Parkinson’s disease. Parkinsonism Relat Disord. 2022 Oct ;103:34-41.

Bourneau-Martin D, Babin M, Grandvuillemin A, Mullet C, Salvo F, Singier A, Cellier M, Fresse A, de Canecaude C, Pietri T, Drablier G, Geniaux
H, Lagarce L, Laroche ML, Briet M ; French Network of Regional Pharmacovigilance Centres.
Adverse drug reaction related to drug shortage : A retrospective study on the French National Pharmacovigilance Database. Br J Clin Pharmacol. 2023 Mar ;89(3):1080-1088

Calviere L, Gathier C S, Rafiq M, Koopman I, Rousseau V, Raposo N, Albucher JF, Viguier A, Geeraerts T, Cognard C, Rinkel G J E, Vergouwen M D I, Olivot JM. Rebleeding After Aneurysmal Subarachnoid Hemorrhage in Two Centers Using Different Blood Pressure Management Strategies.
Front Neurol. 2022 Feb 21 ;13:836268

Chaudhuri K R, Odin P, Ferreira J J, Antonini A, Rascol O, Kurtis M M, Storch A, Bannister K, Soares-da-Silva P, Costa R, Magalhães D, Rocha JF. Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain : rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial.
BMC Neurol. 2022 Mar 12 ;22(1):88.

Chelban V, Nikram E, Perez-Soriano A, Wilke C, Foubert-Samier A, Vijiaratnam N, Guo T, Jabbari E, Olufodun S, Gonzalez M, Senkevich K, Laurens B, Péran P, Rascol O, Le Traon AP, Todd EG, Costantini AA, Alikhwan S, Tariq A, Ng BL, Muñoz E, Painous C, Compta Y, Junque C, Segura B, Zhelcheska K, Wellington H, Schöls L, Jaunmuktane Z, Kobylecki C, Church A, Hu MTM, Rowe JB, Leigh PN, Massey L, Burn DJ, Pavese N, Foltynie T, Pchelina S, Wood N, Heslegrave AJ, Zetterberg H, Bocchetta M, Rohrer JD, Marti MJ, Synofzik M, Morris HR, Meissner WG, Houlden H. Neurofilament light levels predict clinical progression and death in multiple system atrophy. Brain. 2022 Dec 19 ;145(12):4398-4408.

Clarke Lorenzia, Castor-Newton Marie Josiane, Angénieux Olivier, Lapeyre-Mestre Maryse, Gardette Virginie. La population âgée en Guyane : état des lieux et enjeux pour le système de santé. Anal Chem. 2023 Jan ;10 ;95(1):49-69

Coarelli G, Heinzmann A, Ewenczyk C, Fischer C, Chupin M, Monin M L, Hurmic H, Calvas F, Calvas P, Goizet C, Thobois S, Anheim M, Nguyen K, Devos D, Verny C, Ricigliano V A G, Mangin J-F, Brice A, Tezenas du Montcel S, Durr A. Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL) : a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2022 Mar ;21(3):225-23

Corvol J-C, Azulay J-P, Bosse B, Dauvilliers Y, Defebvre L, Klostermann F, Kovacs N, Maltête D, Ondo W G, Pahwa R, Rein W, Thobois S, Valis M, Videnovic A, Rascol O ; THN102-202 Study Investigators. THN 102 for Excessive Daytime Sleepiness Associated with Parkinson’s Disease : A Phase 2a Trial.
Mov Disord. 2022 Feb ;37(2):410-415.

Dague E, Pons V, Roland A, Azaïs J-M, Arcucci S, Lachaize V, Velmont S, Trevisiol E, N’Guyen D, Sénard J-M, Galés C. Atomic force microscopy-single-molecule force spectroscopy unveils GPCR cell surface architecture. Commun Biol. 2022 Mar 10 ;5(1):221

Devignes Q, Daoudi S, Viard R, Lopes R, Betrouni N, Kuchcinski G, Rolland A-S, Moreau C, Defebvre L, Bardinet E, Bonnet M, Brefel-Courbon C, Delmaire C, El Mountassir F, Fluchère F, Fradet A, Giordana C, Hainque E, Houvenaghel J-F, Jarraya B, Klinger H, Maltête D, Marques A, Meyer M, Rascol O, Rouaud T, Tir M, Wirth T, Corvol J-C, Devos D, Dujardin K ; PREDISTIM working group. Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation : Associated Cortical andSubcortical Modifications. J Parkinsons Dis. 2022 ;12(5):1507-1526.

Devos D, Labreuche J, Rascol O, Corvol J-C, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Nicola P, Růžička E, Dušek P, Post B, Bloem B R, Berg D, Maetzler W, Otto M, Habert M-O, Lehericy S, Ferreira J, Dodel R , Tranchant C, Eusebio A, Thobois S, Marques A-R, Meissner W G, Ory-Magne F, Walter U, de Bie R M A, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho M V S , Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo J-P, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland A-S, Nyholm D, Scherfler C, Mangin J-F, Chupin M, Bordet R, Dexter D T, Fradette C, Spino M, Tricta F, Ayton S, Bush A I, Devedjian J-C, Duce J A, Cabantchik I, Defebvre L, Deplanque D, Moreau C ; FAIRPARK-II Study Group. Trial of Deferiprone in Parkinson’s Disease. N Engl J Med. 2022 Dec 1 ;387(22):2045-2055.

Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache J-M, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon M-E, Molimard M, Thiébaut R, de Lamballerie Xa, Joseph J-P, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D, Coverage Study Group. Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes : a randomised controlled trial (COVERAGE). Clin Microbiol Infect. 2022 Jul ;28:1010-1016

Faggianelli F Jr, Loundou A, Baumstarck K, Nathalie S, Auquier P, Eusebio A, Defebvre L, Brefel-Courbon C, Houeto JL, Maltete D, Tranchant C, Derkinderen P, Geny C, Krystkowiak P, Jean-Philippe B, Macia F, Durif F, Poujois A, Borg M, Azulay JP, Witjas T ; NS-Park FCRIN Network. Validation of a non-motor fluctuations questionnaire in Parkinson’s disease. Rev Neurol (Paris). 2022 Apr ;178(4):347-354

Ferré F, Piel-Julian M-L, Tincres F, BA C, Menut R, Ferrier A, Bosch L, Martin C, Labaste F, Montastruc F, Sommet A, Balardy L, Minville V. A High Postoperative Atropinic Burden is Associated with Postoperative Delirium in Elderly Patients with Hip Fracture : Results of the Prospective, Observational, ATROPAGE Trial. Clin Interv Aging. 2022 Dec 30 ;17:1931-1938

Ferreira J J, Poewe W, Rascol O, Stocchi F, Antonini A, Moreira J, Guimarães B, Rocha J-F, Soares-da-Silva P. Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson’s Disease. Mov Disord. 2022 Nov ;37(11):2272-2283.

Ferreira Joaquim J, Poewe Werner, Rascol Olivier, Stocchi Fabriozio, Antonini Angelo, Moreira Joana, Pereira Ana, Rocha José-Francisco, Soares-da-Silva Patricio. Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations : Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial. Neurol Ther. 2022 Sep ;11(3):1409-1425.

Foubert-Samier A, Pavy-Le Traon A, Saulnier T, Le-Goff M, Fabbri M, Helmer C, Rascol O , Proust-Lima C, Meissner W G. An Item Response Theory analysis of the Unified Multiple System Atrophy Rating Scale. Parkinsonism Relat Disord. 2022 Jan ;94:40-44

Georges C, Lloret-Perez S, Ory-Magne F, Fabbri M, Foubert-Samier A, Meissner W G, Rascol O, Pavy-Le Traon A. Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy. Parkinsonism Relat Disord. 2022 Oct ;103:56-59.

Gollion Cédric, Guidolin Brigitte, Lerebours Fleur, Rousseau Vanessa, Barbieux-Guillot Marianne, Larrue Vincent. Migraine and large artery atherosclerosis in young adults with ischemic stroke. Headache. 2022 Feb ;62(2):191-197.

Gomez-Brouchet A, Illac C, Ledoux A, Fortin P-Y, de Barros S, Vabre C, Despas F, Peries S, Casaroli C, Bouvier C, Aubert S, de Pinieux G, Larousserie F, Galmiche L, Talmont F, Pitson S, Maddelein M-L, Cuvillier O. Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma : Relationship with Clinicopathological Parameters. Cancers. 2022 Jan 19 ;14(3):499

Groussolles M, Winer N, Sentilhes L, Biquart F, Massoud M, Vivanti A J, Bouchghoul H, Rozenberg P, Olivier P, Desbriere R, Chauleur C, Perrotin F, Coatleven F, Fuchs F, Bretelle F, Tsatsaris V, Salomon L J, Sananes N, Kayem G, Houflin-Debarge V, Schmitz T, Benoist G, Arnaud C, Ehlinger V, Vayssière C ; Groupe de Recherche en Gynecologie Obstétrique. Arabin pessary to prevent adverse perinatal outcomes in twin pregnancies with a short cervix : a multicenter randomized controlled trial (PESSARONE). Am J Obstet Gynecol. 2022 Aug ;227(2):271.e1-271.e13.

Habek M, Leys F, Krbot Skorić M, Carneiro D R, Calandra-Buonaura G, Camaradou J, Chiaro G, Cortelli P, Falup-Pecurariu C, Granata R, Guaraldi P, Helbok R, Hilz M, Iodice V, Jordan J, Kaal E CA, Kamondi A, Pavy Le Traon A, Rocha I, Sellner J, Senard J-M, Terkelsen A, Wenning G K, Berger T, Thijs R D, Struhal W, Fanciulli A, Collaborators of European Network of Clinical ANS laboratories. Clinical Autonomic Nervous System Laboratories in Europe . Eur J Neurol. 2022 Dec ;29(12):3633-3646.

Jucaite A, Cselényi Z, Kreisl W C, Rabiner E A, Varrone A, Carson R E, Rinne J O, Savage A, Schou M, Johnström P, Svenningsson P, Rascol O, Meissner W G, Barone P, Seppi K, Kaufmann H, Wenning G K, Poewe W, Farde L. Glia Imaging Differentiates Multiple System Atrophy from Parkinson’s Disease : A Positron Emission Tomography Study with [11 C]PBR28 and Machine Learning Analysis.Mov Disord. 2022 Jan ;37(1):119-129.

Kermorgant M, Ferngut P-O, Meissner W G, Arvanitis D N, N’Guyen D, Senard J M, Pavy-Le Traon A. Age and gender differences in cardiovascular autonomic failure in the transgenic PLP-syn mouse, a model of multiple system atrophy. Frontiers in Neurology. 2022 Jun 2 ;13:874155

Kermorgant M, Labrunée M, Despas Fab, Hélissen O, Geeraerts T, Lambert E, Schmidt E, Senard J-M, Arvanitis D N, Nasr N, Traon A P. How does head position induced intracranial pressure changes impact sympathetic activity and cerebral blood flow ? . Auton neurosci. 2022 Dec ;243:103036.

Khedher Khedher L, Bonny JM, Marques A, Durand E, Pereira B, Chupin M, Vidal T, Chassain C, Defebvre L, Carriere N, Fraix V, Moro E, Thobois S, Metereau E, Mangone G, Vidailhet M, Corvol JC, Lehéricy S, Menjot de Champfleur N, Geny C, Spampinato U, Meissner W, Frismand S, Schmitt E, Doé de Maindreville A, Portefaix C, Remy P, Fénelon G, Luc Houeto J, Colin O, Rascol O, Peran P, Durif F ; R study group. Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson’s disease. Neuroimage Clin. 2022 ;36:103231.

Krismer F, Palma JA, Calandra-Buonaura G, Stankovic I, Vignatelli L, Berger AK, Falup-Pecurariu C, Foubert-Samier A, Höglinger G, Kaufmann H, Kellerman L, Kim HJ, Klockgether T, Levin J, Martinez-Martin P, Mestre TA, Pellecchia MT, Perlman S, Qureshi I, Rascol O, Schrag A, Seppi K, Shang H, Stebbins GT, Wenning GK, Singer W, Meissner WG. The Unified Multiple System Atrophy Rating Scale : Status, Critique, and Recommendations. Mov Disord. 2022 Dec ;37(12):2336-2341.

Lang AntonyE, Siderowf Andrew D, Macklin Eric A, Poewe Werner, Brooks David J, Fernandez Hubert H, Rascol Olivier, Giladi Nir, Stocchi Fabrizio, Tanner Caroline M, Postuma Ronald B, Simon David K, Tolosa Eduardo, Mollenhauer Brit, Cedarbaum Jesse M, Fraser Kyle, Xiao James, Evans Karleytonnnn C, Graham DanielleL, Sapir Inbal, Inra ennifer, Hutchison R Matthew, Yang Minhua, Fox Tara, Budd Haeberlein Samantha, Dam Tien ; SPARK Investigators. Trial of Cinpanemab in Early Parkinson’s Disease. N Engl J Med. 2022 Aug 4 ;387(5):408-420.

Montastruc J L, Biron P, Sommet A. Efficacy of COVID-19 vaccines : Several modes of expression should be presented in scientific publications.
Fundam Clin Pharmacol. 2022 Feb ;36(1):218-220

Montastruc J L, Biron P, Sommet A. NVX-Cov2373 Novavax Covid-19 vaccine : A further analysis of its efficacy using multiple modes of expression.
Fundam Clin Pharmacol. 2022 Dec ;36(6):1125-1127

Olivot J-M, Heit J J, Mazighi M, Raposo N, Albucher J-F, Rousseau V, Guenego A, Thalamas C, Mlynash M, Drif A, Christensen S, Sommet A, Viguier A, Darcourt J, Januel A-C, Calviere L, Menegon P, Caparros F, Bonneville F, Tourdias T, Sibon I, Albers GW, Cognard C ; FRAME Investigators. What predicts poor outcome after successful thrombectomy in early time window ? J Neurointerv Surg. 2022 Nov ;14(11):1051-1055.

Pavy-Le Traon A, Foubert-Samier A,Ory-Magne F, Fabbri M, Senard J M, Meissner W G, Rascol O, Amar J. Ambulatory blood pressure and drug treatement for orthostatic hypotension as predictors of mortality in patients with multiple system atrophy. Eur J Neurol. 2022 Apr ;29(4):1025-1034

Rascol O, Medori R, Baayen C, Such P, Meulien D ; AMBLED Study Group. A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson’s Disease. Mov Disord. 2022 May ;37(5):1088-1093.

Rascol O, Tönges L, deVries T, Jaros M, Quartel A, Jacobs D ; ALLAY-LID I and ALLAY-LID II study groups. Immediate-release/extended-release amantadine (OS320) to treat Parkinson’s disease with levodopa-induced dyskinesia : Analysis of the randomized, controlled ALLAY-LID studies.
Parkinsonism Relat Disord. 2022 Mar ;96:65-73.

Rocha JF, Ebersbach G, Lees A, Tolosa E, Ferreira JJ, Poewe W, Rascol O, Stocchi F, Antonini A, Magalhães D, Gama H, Soares-da-Silva P. The safety/tolerability of opicapone when used early in Parkinson’s disease patients with levodopa-induced motor fluctuations : A post-hoc analysis of BIPARK-I and II.
Front Neurol. 2022 Aug 23 ;13:994114.

Roussel M, Lauwers-Cances V, Macro M, Leleu X, Royer B, Hulin C, Karlin L, Perrot A, Touzeau C, Chrétien M-L, Rigaudeau S, Dib M, Nicolas-Virelizier E, Escoffre-Barbe M, Belhadj K, Mariette C, Stoppa A-M, Araujo C, Doyen C, Fontan J, Kolb B, Garderet L, Brechignac S, Malfuson J-V, Jaccard A, Lenain P, Borel C, Hebraud B, Benbrahim O, Dorvaux V, Manier S, Augeul-Meunier K, Vekemans M-C, Randriamalala E, Chaoui D, Caers J, Chaleteix C, Benboubker L, Vincent L, Glaisner S, Zunic P, Slama B, Eveillard J-R, Humbrecht-Kraut C, Morel M, Mineur P, Eisenmann JC, Demarquette H, Richez V, Vignon M, Caillot D, Facon T, Moreau P, Colin AL, Olivier P, Wuilleme S, Avet-Loiseau H, Corre J, Attal M. Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma : an IFM randomized phase 3 study.
Blood. 2022 May 5 ;139(18):2747-2757.

Ruyssen-Witrand A, Rousseau V, Sommet A, Goupille P, Degboe Y, Constantin A. Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients : Data from the DESIR cohort. Joint Bone Spine. 2022 Jul ;89(4):105358

Saulnier T, Philipps V, Meissner W G, Rascol O, Pavy-Le Traon A, Foubert-Samier A, Proust-Lima C. Joint models for the longitudinal analysis of measurement scales in the presence of informative dropout.
Methods. 2022 Jul ;203:142-151.

Suc Anja, Cayzac D, Iannuzzi Stéphanie, Garnier Camille, Bonneau Baptiste, Sommet Agnès. Peacefull : A French mindfulness-based intervention for adolescents with chronic pain a feasibility study. Arch Pediatr. 2022 Nov ;29(8):581-587

Tödt Inken, Al-Fatly Bassam, Granert Olivier, Kühn Andrea, Krack Paul, Rau Joern, Timmermann Lars, Schnitzler Alfons, Paschen Steffen, Helmers Ann-Kristin, Hartmann Andrea, Bardinet Eric, Schuepbach Michael, Barbe Michael T, Dembek TillA, Fraix Valérie, Kübler Dorothee, Brefel-Courbon Christine, Gharabaghi Alireza, Wojtecki Lars, Pinsker Marcus O, Thobois Stephane, Damier Philippe, Witjas Tatiana, Houeto Jean-Luc, Schade-Brittinger Carmen, Vidailhet Marie, Horn Andreas, Deuschl Günther. The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of Life.
Mov Disord. 2022 Feb ;37(2):291-301.

Van Munster M, Stümpel J, Thieken F, Ratajczak F, Rascol , Fabbri M, Clemens T, Czabanowska K, Mestre T A, Pedrosa D J ; iCARE-PD consortium. The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease : A Systematic Review and Meta-Analysis. J Parkinsons Dis. 2022 ;12(6):1807-1831.

PHARMACOVIGILANCE

Aghnatios Lucas , Karsenty Clément, Viard Caroline, de Canecaude Claire, Durrieu Geneviève. Severe hepatitis after sevoflurane anesthesia in an 8-month old child with a Down syndrome : Case report and review of the literature.
Therapie. 2023 Jul-Aug ;78(4):459-462

Araujo M, Hurault-Delarue C, Sommet A, Damase-Michel C, Lacroix I. Topical sertaconazole during in the EFEMERIS database. Mycoses. 2022 April ;65(4):481-489

Azam C, Buscail L, Culetto A, Lapeyre-Mestre M. Cannabinoid-Related Acute Pancreatitis : An Update from International Literature and Individual Case Safety Reports. Drug Saf. 2022 Mar ;45(3):215-235.

Balon M, Tessier S, Damase-Michel C, Cottin J, Lambert A, Thompson M-A, Benevent J, Lacroix I. Adverse drug reactions in pregnant women : Do they differ from those in non-pregnant women of childbearing age ? Thérapie 78(2023) 165-173

Da Costa J, Very E, Rousseau V, Virolle J, Redon M, Taïb S, Revet A, Montastruc F. Comparative Effects of 30 Antipsychotics on Risk of catatonia—An analysis of the WHO Pharmacovigilance Database. J Clin Psychiatry. 2022 Dec 14 ;84(1):21m14238.

Bouhanick B, Brusq C, Bongard V, Tessier S, Montastruc J-L, Senard J-M, Montastruc F, Herin F. Blood pressure measurements after mRNA-SARS-CoV-2 tozinameran vaccination : a retrospective analysis in a university hospital in France. Blood pressure measurements after mRNA-SARS-Cov-2 tozinameran vaccination : a retrospective analysis in a university hospital in France. J Hum Hypertens. 2022 Jun ;36(6):580-581

Foltran D, Delmas C, Flumian C, De P P, Salvo F, Gautier S, Drici M-D, Karsenty C, Montastruc F. Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. Eur Heart J Qual Care Clin Outcomes. 2022 Mar ;2 ;8(2):99-103

Guion-Firmin J, Tessier S, Lepelley M, Faillie J L, Montastruc J-L. Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan : A pharmacovigilance study. Fundam Clin Pharmacol. 2022 Apr ;36(2):378-389

Guion-Firmin J, Tessier S, Montastruc J-L. Diarrhoea and angiotensin II receptor blockers : Is there any difference between the different drugs ? Fundam Clin Pharmacol. 2022 Apr ;36(2):443-447

Hamard J, Rigal M, Gony M, Bagheri H. Lacosamide-induced personality changes : An unexpected adverse effect. Fundam Clin Pharmacol. 2022 Feb ;36(1):224-226.

Hofferer A, Dolladille C, Chretien B, Sassier M, Laugier D, Atzenhoffer M, Bagheri H, Alexendre J, Fedrizzi S, Humbert X. Antidépresseurs et hypertension artérielle : étude cas / non-cas dans la base nationale de pharmacovigilance. L’Encéphale. 2022 Aug ;48(4):404-408

Icard C, Mocquot P, Nogaro JC, Despas F, Gauthier M. Lenalidomide-induced arthritis : A case report and review of literature and pharmacovigilance databases. J Oncol Pharm Pract. 2022 Mar ;28(2):453-456.

[Levy A, Very E, Montastruc F, Birmes P, Jullien A, Richaud L. Case Report : A Case of Valproic Acid-Induced Hyperammonemic Encephalopathy Associated With the Initiation of Lithium : A Re-duplicable Finding.
Front Psychiatry. 2022 May 2 ;13:875636.

Montastruc F, Lafaurie M, Flumian C, De Cnecaude C. Increased reporting of venous and arterial thromboembolic events reported with tixagevimab-cilgavimag for coronavirus disease 2019. Clinical Microbiology and infection. 2022 Dec 1 ;S1198-743X(22)00599-7

Montastruc J L, Durrieu G. Drug-induced hypohidrosis and anhidrosis : analysis of the WHO pharmacovigilance database 2000-2020.
Eur J of clincal Pharmacol. 2022 May ;78(5):887-889

Montastruc J L, Bagheri H, Durrieu G, Lacroix I, Montastruc F. Adverse drug reactions, iatrogenic diseases, drug safety and pharmacovigilance : importance and interest for patients and their physicians. Drug-induced oral complication. 2022 1-6

Moulis G, Crickx E, Thomas L, Massy N, Mahévas M, Valnet-Rabier M-B, Atzenhoffer M, Michel M, Godeau B, Bagheri H, Salvo F ; French Covigilance COVID-19 Vaccine-ITP Study Group. De novo and relapsed immune thrombocytopenia after COVID-19 vaccines : results of French safety monitoring. Blood. 2022 Apr 21 ;139(16):2561-2565.

Murarasu A, Bertoliatti-Fontana G, Massy N, Bagheri H, Treluyer J-M, Regent A, Chouchana L. Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine : A case report with pharmacovigilance analysis. Therapie. 2022 May 21:S0040-5957(22)00102-0.

Ouldali Naïm, Bagheri Haleh, Salvo Francesco, Antona Denise, Pariente Antoine, Leblanc Claire, Tebacher Martine, Micallef Joëlle, Levy Corinne, Cohen Robert, Javouhey Etienne, Bader-Meunier Brigitte, Ovaert Caroline, Renolleau Sylvain, Hentgen Veronique, Kone-Paut Isabelle, Deschamps Nina, De Pontual Loïc, Iriart Xavier, Gras le Guen Christelle, Angoulvant François, Belot Alexandre French Covid-19 Paediatric Inflammation Consortium[Corporate Author] French Pharmacovigilance network[Corporate Author]. Correction to "Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children : A national post-authorization pharmacovigilance study". Lancet Reg Health Eur. 2022 Oct ;21:100468

Ouldali N, Bagheri H, Salvo F, Antona D, Pariente A, Leblanc C, Tebacher M, Micallef J, Levy C, Cohen R, Javouhey E, Bader-Meunier B, Ovaert C, Renolleau S, Hentgen V, Kone-Paut I, Deschamps N, De Pontual L, Iriart X, Gras le Guen C, Angoulvant F, Belot A, French Covid-19 Paediatric Inflammation Consortium[Corporate Author] French Pharmacovigilance network[Corporate Author]. Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children : A national post-authorization pharmacovigilance study.
Lancet Reg Health Eur. 2022 Jun ;17:100393

Quilichini J B, Revet A, Garcia P, Bouquié R, Hamard J, Yrondi A, Montastruc F. Comparative effects of 15 antidepressants on the risk of withdrawal syndrome : A real-world study using the WHO pharmacovigilance database. J Affect Disord. 2022 Jan 15 ;297:189-193

Ramdani Y, Bettuzzi T, Bouznad A, Delaitre L, Nassarmadji K, Didier K, Paul C, Liozon E, Tieu A, Richard-Colmant G, Terrier B, Moulis G, Lafaurie M, Pillebout E, Maillot F, Audemard-Verger A. IgA Vasculitis Following COVID-19 Vaccination/ A French Multicenter Case Series Including 12 Patients. Rheumatol. 2022 Nov 1 ;jrheum. 220545

Saint-Lary L, Diallo a, de Monteynard L A, Paul C, Marchand L, Tubiana R, Warszawski J, Mandelbrot L, Rekacewicz C, Petrov-Sanchez V, Faye A, Sibiude J, Dabis F, Sommet A, Leroy V. In utero exposure to antiretroviral drugs and pregnancy outcomes : Analysis of the French ANRS pharmacovigilance database.
Br J Clin Pharmacol. 2022 Mar ;88(3):942-964.

Strumia M, Perrin M L, Patras de compaigno E, Conte C, Montastruc F, Lapeyre-Mestre M, Sibaud V, Despas Fabien. Dermatological adverse drug reactions of anticancer drugs : International data of pharmacovigilance : Vigibase. Therapie. 2022 Mar-Apr ;77(2):219-227

Teboul A, Chouchana L, Durrieu G, Eftekhari P, Treluyer J M, Mouthon L, Chaigne B. Drug-induced eosinophilic fasciitis : A dual pharmacovigilance analysis. J Am Acad Dermatol. 2022 Jun ;86(6):1372-1375.

ADDICTOVIGILANCE

Delage N, Cantagrel N, Delorme J, Pereira B, Dualé C, Bertin C, Chenaf C, Kerckhove N, Laporte C, Picard P, Roussin A, Authier N. Transcultural validation of a French–European version of the Prescription Opioid Misuse Index Scale (POMI-5F). Can J Anaesth. 2022 Aug ;69(8):1042-1052

Jouanjus E, Gibaja V, Fabre F, Lapeyre-Mestre M ; OSIAP Working Group on Opioid cough suppressants. Medical prescription forms of opioid cough suppressants falsified by the patients before and after they switched from over-the-counter to prescription-only in France. Br J Pharmacol. 2022 Apr ;88(4):1713-1721

Lapeyre-Mestre M. Addictovigilance in women, the hidden part of the iceberg ? . Therapie 2022 Oct 7 ;S0040-5957(22)00175-5.

Revol B, Lapeyre-Mestre M, Fouilhé Sam-Laï N, Jouanhus E. Association between NMDAR antagonists, drug abuse and dependance : A disproportionality analysis from the WHO pharmacovigilance database.
Br J Clin Pharmacol. 2022 Nov ;88(11):4937-4940

Roussin A, Soeiro T, Fouque C, Jouanjus E, Frauger E, Fouilhé N, Mallaret M, Micallef J, Lapeyre-Mestre M, the French addictovigilance Network Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018 : Evidence from the triangulation of addictovigilance data. Br J Clin Pharmacol. 2022 Aug ;88:3789-3802

PHARMACO-EPIDEMIOLOGIE

Benevent J, Hurault-Delarue C, Araujo M, Revet A, Sommet A, Lacroix I, Damase-Michel C. Prenatal Drug Exposure in Children with a History of Neuropsychiatric Care : A Nested Case-Control Study.
Front Psychiatry. 2022 Mar 22 ;13:795890

Blayac L, Ponte C, Lavaud M, Micallef J, Lapeyre-Mestre M. Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018 : Insights of the annual cross sectional OPPIDUM survey . Thérapie. 2022 Oct 8 ;S0040-5957(22)00171-8.

Cao Thi Xuan D, Filliter C, Montastruc F, Yu Oriana Hoi Y, Fergusson E, Rej S, Azoulay L, Renoux C. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord. 2022 Dec 1 ;318:231-237.

Chu Thanh H, Rueter M, Palmaro A, Lapeyre-Mestre M. Potential inappropriate use of strong opioid analgesics in cancer outpatients during the last year of life in France and associated factors. Br J Clin Pharmacol. 2022 Feb ;88(4):1691-1703.

Conte C, Vayr F, Pajiep M-C, Despas F, Huguet F, Lapeyre Mestre M, Gauthier M, Herin F. Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund : a nationwide cohort study. Support Care Cancer. 2022 Jun ;30(6):5431-5440.

Dolk H, Damase-Michel C, Morris J K, Loane M. COVID-19 in pregnancy-what study designs can we use to assess the risk of congenital anomalies in relation to COVID-19 disease, treatment and vaccination ?
Paediatr Perinat Epidemiol. 2022 Jul ;36(4):493-507

Errahmani MY, Thariat J, Ferrières J, Panh L, Locquet M, Lapeyre-Mestre Maryse, Guernec G, Bernier MO, Boveda S, Jacob S. Risk of pacemaker implantation after radiotherapy for breast cancer : A study based on French nationwide health care database sample. Int J Cardiol Heart Vasc. 2021 Dec 25 ;38:100936.

Ferreira de Matos C, Comont T, Castex M-P, Lafaurie M, Walter O, Moulis G. Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids : a comprehensive review. Expert Rev of Hematol. 2022 Dec ;15(12):1045-1054

Freyche C, Zacarin A, Bagheri H. [Potentially inappropriate psychotropic drug prescription in elderly people in West Occitanie area].
Therapie. 2022 Sep-Oct ;77(5):541-548.

Gosset A, Denuelle M, Valton L, Sommet A, Bénévent J, Tremollières F. Interactions between antiseizure medications and contraception : A study about the knowledge of patients and their specialist physicians. Epilepsy Behav. 2022 Apr ;129:108627

Guilleminault L, Mounié M, Sommet A, Camus C, Didier A, Reber L L, Costa N, Conte C. Healthcare resource consumption prior to asthma-related death : a nationwide descriptive study. Ther Adv Respir Dis. 2022 Jan-Dec ;16:17534666221130217

Hirtz C, Adam G, Raposo N, Fabre N, Ducros A, Calviere L, Rousseau V, Albucher J F, Olivot J M, Bonneville F, Viguier A. Diagnostic utility of T2*-weighted GRE in migraine with aura attack. The cortical veins sign. Cephalalgia. 2022 Jul ;42(8):730-738

Jordan S, Bromley R, Damase-Michel C, Given J, Komninou S, Loane M, Marfell N, Dolk H. Breastfeeding, pregnancy, medecines, neurodevelopment, and population databases : the information desert.
Int Breastfeed j. 2022 Aug 2 ;17(1):55

Jourdes A, Lafaurie M, Moulis G, Delobel P, Faruch M, Sommet A, Martin-Blondel G. Comparison of the first and second wawes of coronavirus disease in Toulouse, France. Infectious Diseases Now. 2022 Feb ;52(1):49-52

Khosrow-Khavar F, Azoulay L, Montastruc J L, Montastruc F, Renoux C. Aromatase inhibitors and the incidence of Parkinson disease : A population-based cohort study. Cancer. 2022 Jun 15 ;128(12):2339-2347

Lafaurie M, Lapeyre-Mestre M, Sailler L, Sommet A, Moulis G. Risk of Immune Thrombocytopenia After Influenza Vaccine.
JAMA Intern Med. 2022 Apr 1 ;182(4):444-445

Lajaunie R, Mainardi I, Gasnault J, Rousseau V, Tarantino A G, Sommet A, Cinque P, Martin-Blondel G, PML study group. Outcome of progressive Multifocal Leukoencephalopathy Treated by Interleukin-7. Ann Neurol. 2022 Apr ;91(4):496-505

Lavergne J, Debin M, Blanchon T, Colizza V, Dassieu L, Gimenez L, Kengne-Kuetche C, Lapeyre-Mestre M, Dupouy J. Perceived risk of opioid use disorder secondary to opioid analgesic medication use by the general population in France.
Eur J Pain. 2022 Mar ;26(3):729-739

Lee Siang I, Azcoaga-Lorenzo A, Agrawal U, Kennedy J I, Fagbamigbe Adeniyi F, Hope H, Subramanian A, Anand A, Taylor B, Nelson-Piercy C, Damase-Michel C, Yau C, Crowe F, Santorelli G, Eastwood K-A, Vowles Z, Loane M, Moss N, Brocklehurst P, Plachcinski R, Thangaratinam S, Black M, O’Reilly D, Abel K M, Brophy S, Niranthnarakumar K, McCowan C, MuM-PreDICT Group. Epidemiology of pre-existing multimorbidity in pregnant wome in the UK in 2018 : a cross-sectional study.
The Lancet. 2022 Feb 11 ;22(1):120

Lépine B, Debin M, Dassieu L, Gimenez L, Palmaro A, Ponté C, Swital M, Lapeyre-Mestre M, Blanchon T, Dupouy J. Prescribing buprenorphine for opioid use disorder in primary care : A survey of French general practitioners in the sentinelles network.
J Subst Abuse Treat. 2022 Dec ;143:108891

Moulis G, Germain J, Rueter M, Lafaurie M, Aroichane M, Comont T, Mahévas M, Viallard J-F, Chèze S, Ebbo M, Audia S, Leclerc-Teffahi S, Sommet A, Beyne-Rauzy O, Michel M, Godeau B, Lapeyre-Mestre M, CARMEN investigators group. Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration : The multicenter, prospective ELEXTRA study. Am J Hematol. 2022 Feb 1 ;97(2):E40-E44

Paternoster M, Steichen O, Lapeyre-Mestre M, Blanchon T, Rossignol L, Vilcu A-M, Launay T, Sarazin M, Bagheri H, Conte C, Turbelin C, Hanslik T, Souty C. Risk of Bleeding Associated With Nonsteroidal Anti-inflammatory Drug Use in Patients Exposed to Antithrombotic Therapy : A Case-Crossover Study.
J Clin Pharmacol. 2022 May ;62(5):636-645.

Perri-Plandé J, Miremont-Salamé G, Micallef J, Herman C, Baumevieille M, Abriat F, Lapeyre-Mestre M, Haramburu F, Daveluy A ; French Addictovigilance Network. A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019).
Drug Saf. 2022 Jan ;45(1):37-44

Revet A, Moulis G, Raynaud J P, Bui Eric, Lapeyre-Mestre M. Use of the French national health insurance information system for research in the field of mental health : Systematic review and perspectives.
Fundam Clin Pharmacol. 2022 Feb ;36(1):16-34

Rueter M, Baricault B, Lapeyre-Mestre M. Patterns of opioid analgesic prescribing in cancer outpatients during the last year of life in France : A pharmacoepidemiological cohort study based on the French health insurance database. Therapie. 2022 Nov-Dec ;77(6):703-711.

Scailteux L M, Despas F, Balusson F, Campillo-Gimenez B, Mathieu R, Vincendeau S, Happe A, Nowak E, Kerbrat S, Oger E. Hospitalization for adverse events under abiraterone or enzalutamide exposure en real-world setting : A French population-based study on prostate cancer patients. Br J Clin Pharmacol. 2022 Jan ;88(1):336-346

Souty C, Vilcu A M, Conte C, Saint-Salvi B, Sarazin M, Rossignol L, Blanchon T, Hanslik T, Lapeyre-Mestre M, Steichen O. Risk of hospitalisation for serious colchicine intoxication after concomitant exposure to pristinamycin : A nationwide healthcare database study.Therapie. 2023 Nov-Dec ;78 (6)769-772

Thurin H N, Pajouheshnia R, Roberto G, Dodd C, Hyeraci G, Bartolini C, Paoletti O, Nordeng H, Wallach-Kildemoes H, Ehrenstein V, Dudukina E, MacDonald T, De Paoli G, Loane M, Damase-Michel C, Beau A-B, Droz-Perroteau C, Lassalle R, Bergman J , Swart K , Schink T, Cavero-Carbonell C, Barrachina-Bonet L, Gomez-Lumbreras A, Giner-Soriano M, Aragón M, Neville A J, Puccini A, Pierini A, Ientile V, Trifirò G, Rissmann A, Leinonen M K, Martikainen V, Jordan S, Thayer D, Scanlon I, Georgiou M E, Cunnington M, Wood M E, Lupattelli A, Palmsten K, Bandoli G, Hurault-Delarue C, Damase-Michel C, Chambers CD, Nordeng HME, van Gelder MMHJ. From Inception to ConcePTION : Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding. Clin Pharmacol Ther. 2022 Jan ;111(1):321-331

Vabre Cl, Araujo M, Damase-Michel C, Hurault-Delarue C, Lacroix I. Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss – An observational study using the EFEMERIS database. Thérapie 2022 Jul-Aug ;77(4):405-412

Vabre C, Zelmat Y, Gauthier M, Pajiep M, Conte C, Lapeyre-Mestre M, Dray-Spira R, Zureik M, Despas F. Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia : Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system. Am J Hematol. 2022 Aug ;97(8):E307-E309.

Walter O, Cougoul P, Maquet J, Bartolucci P, Lapeyre-Mestre M, Lafaurie M, Moulis G. Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood 2022 Jun ;139(26):3771-3777

Wood Mollie E, Lupattelli A, Palmsten K, Bandoli G, Hurault-delarue C, Damase-Michel C, Chambers C D, Nordeng H M E, Van Gelder mM M.H.J. Longitudinal methods for modeling exposures in Pharmacoepidemiologic studies in pregnancy. Epidemiol rev. 2022 Jan 14 ;43(1):130-146

Zacarin A, Zogheib ML, Ruiz AC, Bagheri H. [Prevalence of statins prescriptions among the elderly in nursing homes in West Occitania]. Therapie. 2022 May-Jun ;77(3):384-386.

Zelmat Y, Conte C, Noize P, Vabre C, Pajiep M, Lafaurie M, Lapeyre-Mestre M, Despas F. Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study.Br J Clin Pharmacol. 2022 Oct 26.

INFORMATIONS SUR LE MEDICAMENT

Fabbri M, Ferreira J J, Rascol O. COMT Inhibitors in the Management of Parkinson’s Disease. CNS Drugs. 2022 Mar ;36(3):261-282.

Kiladjian J-J, Despas F. Hemato-oncopharmacology : Drugs and cancer. Thérapies. 2022 Mar-Apr ;77(2):149-150

Mocquot P, Mossazadeh Y, Lapierre L, Pineau F, Despas F. The pharmacology of blinatumomab : state of the art on pharmacodynamics, pharmacokinetics, adverse drug reactions and evaluation in clinical trials. J Clin Pharm Ther. 2022 Sep ;47(9):1337-1351.

Pericaud A, Straczek C, Montastruc f, Leboyer M, Yrondi A, Arbus C. Use of antidepressants in unipolar depression in the elderly. Encephale. 2022 Aug ;48(4):445-454

Taillefer de Laportalière T, Yrondi A, Jullien A, Cestac P, Montastruc F. How to deprescribe esketamine in resistant depression ? A point of view after first clinical uses. Epidemiol Psychiatr Sci. 2022 Jan 11 ;31:e4.